MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 216 filers reported holding MEDIVATION INC in Q4 2013. The put-call ratio across all filers is 1.03 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,228,000 | -43.8% | 20,365 | -57.1% | 0.00% | -66.7% |
| Q1 2016 | $2,185,000 | +5.1% | 47,512 | +10.5% | 0.00% | +50.0% |
| Q4 2015 | $2,078,000 | +14.6% | 42,984 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,813,000 | -12.5% | 42,658 | +135.2% | 0.00% | 0.0% |
| Q2 2015 | $2,071,000 | +66.9% | 18,139 | +88.7% | 0.00% | +100.0% |
| Q1 2015 | $1,241,000 | +34.5% | 9,615 | +3.7% | 0.00% | 0.0% |
| Q4 2014 | $923,000 | -2.9% | 9,269 | -3.6% | 0.00% | 0.0% |
| Q3 2014 | $951,000 | +28.3% | 9,616 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $741,000 | +11.1% | 9,616 | -7.2% | 0.00% | 0.0% |
| Q1 2014 | $667,000 | +3.6% | 10,358 | +2.7% | 0.00% | 0.0% |
| Q4 2013 | $644,000 | +6.4% | 10,088 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $605,000 | -97.7% | 10,088 | -98.1% | 0.00% | -97.1% |
| Q2 2013 | $26,521,000 | – | 539,036 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |